Tier-two pharma picks show solid fundamentals, but Eli Lilly (LLY) stock stands out for its growth potential. Read here for ...

Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

An empty reserve undermines national preparedness for health crises like pandemics and bioterrorism where rapid access to ...

The industry’s reputation surged during the COVID-19 pandemic, according to PatientView’s annual survey of patient groups, peaking two years ago, when 60% of those surveyed said pharma’s ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

The partnership grants Envirotainer exclusive global rights to offer the innovative Swiss Airtainer as part of its full ...

Nigeria’s local manufacturers are recording 12% reduction in the cost of production as a result of the ongoing implementation ...

This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.